Bottom line
Is DSTL a good fund? The bottom line
DSTL is a managed large value ETF from Grayscale.
It charges 0.39% — about $39 a year on every $10,000 invested, cheaper than 87% of large value funds we track.
It returned +8.6% over one year, +11.6% a year over five years (as of Dec 31, 2025, per its prospectus).
With $2.1 billion in net assets and 108 holdings, its largest position is AbbVie Inc (3.4%) and the top 10 make up 20% of the portfolio.
What stands out
- Low cost: cheaper than 87% of large value peers
Updated Nov 19, 2026
What DSTL invests in
The Distillate U.S. Fundamental Stability & Value ETF (the Fund) seeks long-term capital appreciation.
The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing in U.S.-listed equity securities, selected based on the Advisers assessment of a companys valuation, cash flow stability, and balance sheet quality (fundamental factors), as described below. In selecting securities for the Fund, Distillate Capital Partners LLC, the Funds investment adviser (Distillate or the Adviser), first considers companies that meet the Advisers criteria for (i) profitability, (ii) historical cash flow, and (iii) liquidity (based on the average daily traded value of the security). Companies that satisfy such criteria are then reviewed using the Advisers proprietary measures of: (i) the companys valuation, which takes into account the companys free cash flow yield (a measure comparing a companys normalized free cash flow to its enterprise value)…
From the fund's prospectus (filed Jan 26, 2026).
DSTL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DSTL | +8.6% | +11.6% | — |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What DSTL costs
On a $10,000 investment, DSTL's 0.39% expense ratio costs about $39 a year. The prospectus estimates $493 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
DSTL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | AbbVie Inc ABBV | 3.35% |
| 2 | Merck & Co Inc MRK | 2.94% |
| 3 | QUALCOMM Inc QCOM | 2.37% |
| 4 | Booking Holdings Inc BKNG | 1.81% |
| 5 | Uber Technologies Inc UBER | 1.75% |
| 6 | Salesforce Inc CRM | 1.71% |
| 7 | Altria Group Inc MO | 1.59% |
| 8 | Cigna Group/The CI | 1.51% |
| 9 | T-Mobile US Inc TMUS | 1.51% |
| 10 | Comcast Corp CMCSA | 1.50% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20% of the fund. See all top 25 holdings and asset mix →